Financial statements Laboratorium Obrazowania Molekularnego I Rozwoju Technologii Uniwersytetu Medycznego W Białymstoku
Balance sheet data of LABORATORIUM OBRAZOWANIA MOLEKULARNEGO I ROZWOJU TECHNOLOGII UNIWERSYTETU MEDYCZNEGO W BIAŁYMSTOKU
Year
|
2017
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 0,00 | 4 298 511,69 | 5 259 507,23 | 7 425 686,62 | 10 551 309,78 | 13 802 399,10 |
A. Fixed assets | 0,00 | 568 390,03 | 318 861,19 | 442 536,49 | 5 058 781,13 | 4 239 596,26 |
B. Current assets | 1 783 437,34 | 3 730 121,66 | 4 940 646,04 | 6 983 150,13 | 5 492 528,65 | 9 562 802,84 |
C. Share capital contributions (basic funds) | - | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - | - |
Total liabilities | 1 666 906,62 | 4 298 511,69 | 5 259 507,23 | 7 425 686,62 | 10 551 309,78 | 13 802 399,10 |
A. Equity | 500 000,00 | 3 533 508,51 | 4 970 554,94 | 7 182 020,60 | 8 946 362,20 | 11 870 353,19 |
B. Liabilities and provisions for liabilities | 116 530,72 | 765 003,18 | 288 952,29 | 243 666,02 | 1 604 947,58 | 1 932 045,91 |
I. Long-term liabilities | 116 530,72 | 0,00 | 0,00 | 0,00 | 0,00 | - |
II. Short-term liabilities | 64 725,96 | 765 003,18 | 288 952,29 | 243 666,02 | 1 604 947,58 | 1 932 045,91 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.